Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy

Most chronic spontaneous urticaria (CSU) patients are female, and pregnancy can aggravate the disease activity of patients, but little is known about the efficacy and safety of omalizumab in pregnant CSU patients. We report two pregnant CSU patients treated with omalizumab and review the published i...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Shuang-Lu Liao, Miao Yu, Zuo-Tao Zhao, Marcus Maurer
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Subjects:	omalizumab pregnancy chronic spontaneous urticaria wheals angioedema
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.652973/full

Similar Items

Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?
by: Thomas B. Casale, MD, et al.
Published: (2024-08-01)

A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria
by: Adam Friedman, et al.
Published: (2024-05-01)

Urticaria and Angioedema – More than just Skin Deep!
by: Jeanette Holtzhausen
Published: (2016-11-01)

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
by: Thomas B. Casale, et al.
Published: (2023-09-01)

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
by: Elizabeth García-Gómez, et al.
Published: (2022-05-01)

UCOMB-real life data: treatment strategies for chronic urticaria patients with comorbidities
by: Petra Staubach, et al.
Published: (2024-12-01)

Chronic inducible urticaria – having more than one is common and clinically relevant
by: Marina Lebedkina, et al.
Published: (2025-06-01)

Retrospective analysis of the treatment of 61 cases of chronic spontaneous urticaria with omalizumab
by: Shanshan OU, et al.
Published: (2023-04-01)

Omalizumab Use in Chronic Spontaneous Urticaria during Pregnancy and a Four Years’ Follow-Up: A Case Report
by: Laura Michelina Losappio, et al.
Published: (2020-10-01)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
by: Öner Özdemir
Published: (2023-08-01)

Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients
by: Kiran Godse, et al.
Published: (2016-01-01)

Alopecia Areata after Omalizumab Treatment for Chronic Spontaneous Urticaria
by: Eli Magen
Published: (2019-07-01)

Urticaria crónica idiopática o urticaria espontánea y omalizumab. Revisión del tema a propósito de un caso
by: Giovanni Sedó Mejía, et al.
Published: (2014-05-01)

Clinical observation of desloratadine combined with omalizumab in the treatment of chronic spontaneous urticaria
by: Zhiwei SHANG, et al.
Published: (2022-02-01)

Omalizumab in the treatment of chronic spontaneous urticaria – literature review and own experience
by: Joanna Dawicka, et al.
Published: (2016-02-01)

Efficacy of omalizumab treatment for patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU) in Taiwan
by: Che-Wen Yang, et al.
Published: (2017-12-01)

The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management
by: Mario Sánchez-Borges, et al.
Published: (2021-06-01)

Omalizumab for the management of refractory chronic spontaneous urticaria
by: P C Kathuria, et al.
Published: (2022-01-01)

Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
by: Anthony F. LaCava, et al.
Published: (2023-08-01)

Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study
by: Vera G. Kalugina, et al.
Published: (2020-08-01)

Experience of long-term use of anti-IgE therapy in a patient with chronic spontaneous urticarial
by: E. A. Sobko, et al.
Published: (2022-04-01)

COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports
by: Angelo Massimiliano D'Erme, et al.
Published: (2023-08-01)

Effectiveness of transitioning from omalizumab to dupilumab in chronic spontaneous urticaria patients with inadequate response to omalizumab
by: Koremasa Hayama, M.D., Ph.D., et al.
Published: (2025-08-01)

Omalizumab treatment can increase the serum levels of vitamin D in patients with chronic spontaneous urticaria
by: MENG Zhen, et al.
Published: (2025-03-01)

Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China
by: Ao Wang, MD, et al.
Published: (2022-12-01)

Mapping the intellectual structure of the research of omalizumab in chronic spontaneous urticaria: A bibliometric analysis
by: Yuxu Yao, MD, et al.
Published: (2024-05-01)

Treatment of chronic spontaneous urticaria with a single dose of omalizumab: A study of four cases
by: Radhakrishnan Subramaniyan, et al.
Published: (2016-01-01)

CD4+CCR5+ T cells and CCL3+ mast cells are increased in the skin of patients with chronic spontaneous urticaria
by: Raeda Mubariki, et al.
Published: (2024-07-01)

Omalizumab withdrawal outcomes in chronic spontaneous urticaria are linked with baseline IgE and eosinophil levels
by: Ramit Maoz-Segal, MD, et al.
Published: (2024-05-01)

Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study
by: Michihiro Hide, et al.
Published: (2023-04-01)

Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study on Effectiveness, Safety and Predictors of Treatment Outcome
by: Chen J, et al.
Published: (2024-08-01)

Predictors of Early Response and Relapse in Chronic Spontaneous Urticaria Treated with Omalizumab: The Role of Age, Sex, Disease Duration, and UAS7
by: Mehmet Enes Güner, et al.
Published: (2025-10-01)

Predictors of response to omalizumab and relapse in chronic spontaneous Urticaria: a narrative review focusing on parameters available in routine clinical practice
by: Laura Mateu-Arrom, et al.
Published: (2025-10-01)

The use of an urticaria control test for the evaluation of omalizumab treatment response in patients diagnosed with chronic urticaria
by: Burhan Engin, et al.
Published: (2020-12-01)

Exploring Machine Learning Techniques to Predict the Response to Omalizumab in Chronic Spontaneous Urticaria
by: Davide Stefano Sardina, et al.
Published: (2021-11-01)

Diagnostics and treatment of chronic urticaria in the family doctor's office
by: Agnieszka Malita, et al.
Published: (2018-09-01)

Utilidad clínica del omalizumab en urticaria crónica inducible
by: Ricardo Cardona
Published: (2018-06-01)

Urticaria and other mimickers of urticaria
by: María Isabel Rojo-Gutierrez, et al.
Published: (2025-02-01)

Different doses and courses of omalizumab for patients with chronic spontaneous urticaria: A systematic review with meta-analysis and trial sequential analysis
by: Haiyan Qin, MD, et al.
Published: (2024-04-01)

Case Report: Safety and Efficacy of Omalizumab in a 13-Year-Old Patient With Chronic Spontaneous Urticaria and Type 1 Diabetes
by: Paolo Del Barba, et al.
Published: (2022-04-01)